Advertisement
Postpartum readmission rates rose from 2004 to 2011

Postpartum Readmission Within Six Weeks of Delivery on the Rise

0
Readmission more likely among black, publically insured patients with comorbidities
The diagnosis and management of polycystic ovary syndrome is discussed in a case vignette published online July 6 in The New England Journal of Medicine.

Case Vignette Addresses Diagnosis, Management of PCOS

0
Treatment decisions should be informed by patient priorities -- in this case hirsutism, irregular menses
Neratinib and veliparib-carboplatin appear to be effective in women with specific subtypes of breast cancer

Neratinib Active in HER2-Positive, HR-Negative Breast Cancer

0
And higher pathologic complete response for veliparib-carboplatin in triple-negative breast cancer
Only about half of trials registered at ClinicalTrials.gov are listed in the largest data-sharing repository

Many Clinical Trials Are Not Listed in Data-Sharing Repository

0
Fifty-three percent of randomized clinical trials were listed at Clinical Study Data Request website
Women with a history of cervical intraepithelial neoplasia 2 or 3 have increased risks of subsequent development of anal

Risk of Noncervical Anogenital Cancer Up With History of CIN2/3

0
Women with history of CIN2/3 have increased long-term risk of anal, vulvar, vaginal cancers
The magnitude of the association between a multilocus genetic risk score for body mass index and BMI is larger for individuals born in later birth cohorts

Genetic Risk Score Impact on BMI Varies Across Birth Cohorts

0
Larger magnitude of association between genetic risk score for BMI and BMI in later birth cohorts
A mindful self-compassion program can reduce depression

Mindful Self-Compassion Program Beneficial in Diabetes

0
Emotional and metabolic benefits with reductions in depression and glycated hemoglobin
In an experimental study

Anti-Anxiety Medication May Limit Empathetic Behavior

0
Midazolam-treated rats show less helping behavior than those receiving saline or no injection
Limiting first trimester screening (FTS) by cell-free fetal (cff) DNA to only patients in certain risk categories may be a feasible cost-containing strategy

Two-Stage Screening Could Be Cost-Effective for Trisomy

0
Cost-benefit analysis of hypothetical model based on implementation of cell-free fetal DNA
Patients with heterozygous familial hypercholesterolemia have a significantly increased risk for coronary heart disease and atherosclerotic cardiovascular disease

CVD Risks Way Up in Familial Hypercholesterolemia

0
Clinician-patient discussions on guideline-supported therapies can be informed by data